The Department of Emergency Medicine, Cooper University Hospital, Cooper Medical School of Rowan University, One Cooper Plaza, K152, Camden, NJ, 08103, USA.
Departments of Emergency Medicine and Anesthesiology, Division of Critical Care Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Syst Rev. 2018 Oct 22;7(1):171. doi: 10.1186/s13643-018-0840-4.
Respiratory failure requiring mechanical ventilation is a common manifestation of end-organ damage among patients with sepsis and has a high morbidity and mortality rate, as well as substantial associated treatment costs. Considering the burden of this condition, there is great need to identify novel, pragmatic therapies to improve outcomes in this population. Hypercapnia has shown benefits in several different ex vivo and in vivo models of lung injury. However, it is currently unclear if hypercapnia can confer clinical benefit among patients with sepsis. The objective of this systematic review is to collate the biomedical literature of preclinical and clinical studies testing the effects of higher PaCO levels in the setting of sepsis.
We will perform a qualitative systematic review of preclinical and clinical studies evaluating the effects of hypercapnia in sepsis. We will search CENTRAL, PubMed, CINAHL, and EMBASE using a comprehensive strategy. We will screen the reference lists of the articles we select for inclusion to identify additional studies for potential inclusion. Two independent reviewers will review all search results. Upon inclusion of articles, we will extract data using a standardized form. We will use tables to describe the study type, population included, exposure and control groups, outcome measures, and effects of exposure on outcome measures compared to controls.
This systematic review aims to synthesize the world's literature on the effects of hypercapnia in the setting of sepsis. We expect this systematic review will find that majority of the studies will demonstrate a potential benefit of higher PaCO levels in sepsis. The results of this systematic review will contribute to the understanding of the effects of hypercapnia in the setting of sepsis and promote future research of PaCO management in mechanically ventilated patients with sepsis.
The systematic review is registered in the PROSPERO international prospective register of systematic review (PROSPERO # CRD42018086703 ).
需要机械通气的呼吸衰竭是脓毒症患者终末器官损伤的常见表现,具有较高的发病率和死亡率,以及大量相关的治疗费用。鉴于这种情况的负担,非常需要确定新的实用疗法,以改善该人群的预后。高碳酸血症在几种不同的离体和体内肺损伤模型中都显示出了益处。然而,目前尚不清楚高碳酸血症是否能为脓毒症患者带来临床益处。本系统评价的目的是整理生物医学文献,其中包括在脓毒症背景下测试更高 PaCO2 水平影响的临床前和临床研究。
我们将对评估高碳酸血症在脓毒症中的作用的临床前和临床研究进行定性系统评价。我们将使用综合策略对 CENTRAL、PubMed、CINAHL 和 EMBASE 进行搜索。我们将筛选我们选择纳入的文章的参考文献列表,以确定其他可能纳入的研究。两名独立的审查员将审查所有搜索结果。在纳入文章后,我们将使用标准化表格提取数据。我们将使用表格来描述研究类型、纳入人群、暴露组和对照组、结局指标以及与对照组相比暴露对结局指标的影响。
本系统评价旨在综合世界范围内关于高碳酸血症在脓毒症中的作用的文献。我们预计,本系统评价将发现,大多数研究将表明在脓毒症中较高 PaCO2 水平可能有潜在益处。本系统评价的结果将有助于了解高碳酸血症在脓毒症中的作用,并促进未来对机械通气脓毒症患者 PaCO2 管理的研究。
本系统评价已在 PROSPERO 国际前瞻性系统评价注册库(PROSPERO # CRD42018086703 )中注册。